The clinical management of heparin-induced thrombocytopenia.

  title={The clinical management of heparin-induced thrombocytopenia.},
  author={John G. Kelton},
  journal={Seminars in hematology},
  volume={36 1 Suppl 1},
Heparin-induced thrombocytopenia (HIT) is an immunologic complication of drug therapy with potentially serious venous and arterial thrombotic sequelae. Recent studies have provided insight into the molecular and cellular basis of HIT underlying the diagnosis and treatment of this syndrome. Because various approaches to HIT treatment have resulted in mixed success, the use of heparin substitutes, other anticoagulant agents, and adjunctive therapy needs to be clarified. For patients with pre… CONTINUE READING

Similar Papers

Loading similar papers…